RFP Financial Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12
Closed -$239 163
2024
Q2
$239 Hold
12
﹤0.01% 881
2024
Q1
$239 Hold
12
﹤0.01% 832
2023
Q4
$269 Hold
12
﹤0.01% 853
2023
Q3
$243 Hold
12
﹤0.01% 879
2023
Q2
$307 Buy
+12
New +$316 ﹤0.01% 917
2023
Q1
Sell
-12
Closed -$325 749
2022
Q4
$325 Buy
+12
New +$293 ﹤0.01% 882

Other funds holding AVNS

RFP Financial Group's AVNS Position: Q3 2024 in Review

RFP Financial Group sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 12 shares — an estimated $239 sold.

RFP Financial Group first reported a position in AVNS in Q4 2022 and held it in 6 quarters. The position peaked at $325 in Q4 2022. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

  • RFP Financial Group reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 12 Avanos Medical shares in Q3 2024, an estimated $239.
  • RFP Financial Group first reported a position in Avanos Medical in Q4 2022 and held it in 6 quarters.
  • RFP Financial Group's Avanos Medical position peaked at $325 in Q4 2022.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.